These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 36986430)

  • 21. Exploration of potential inhibitors for autophagy-related protein 8 as antileishmanial agents.
    Rahman F; Ali R; Tabrez S; Mobeen A; Akand SK; Arish M; AlAsmari AF; Ali N; Rub A
    Chem Biol Drug Des; 2022 Jun; 99(6):816-827. PubMed ID: 35147279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP5122A1 encodes an essential sterol C4-methyl oxidase in
    Jin Y; Basu S; Feng M; Ning Y; Munasinghe I; Joachim AM; Li J; Madden R; Burks H; Gao P; Perera C; Werbovetz KA; Zhang K; Wang MZ
    Res Sq; 2023 Jul; ():. PubMed ID: 37546914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
    Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
    J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
    Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
    Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Holanamine, a Steroidal Alkaloid from the Bark of
    Goel N; Gupta VK; Garg A; Bhoumik A; Biswas R; Natarajan R; Majumder HK; Jaisankar P
    ACS Infect Dis; 2023 Jan; 9(1):162-177. PubMed ID: 36417798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studies.
    Hassan AHE; Mahmoud K; Phan TN; Shaldam MA; Lee CH; Kim YJ; Cho SB; Bayoumi WA; El-Sayed SM; Choi Y; Moon S; No JH; Lee YS
    Eur J Med Chem; 2023 Mar; 250():115211. PubMed ID: 36827952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against
    Phan TN; Baek KH; Lee N; Byun SY; Shum D; No JH
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32340370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of
    Qureshi KA; Imtiaz M; Al Nasr I; Koko WS; Khan TA; Jaremko M; Mahmood S; Fatmi MQ
    Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36139985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies.
    Shokri A; Abastabar M; Keighobadi M; Emami S; Fakhar M; Teshnizi SH; Makimura K; Rezaei-Matehkolaei A; Mirzaei H
    J Glob Antimicrob Resist; 2018 Sep; 14():260-265. PubMed ID: 29793051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiparasitic dibenzalacetone inhibits the GTPase activity of Rab6 protein of Leishmania donovani (LdRab6), a potential target for its antileishmanial effect.
    Chauhan IS; Marwa S; Rao GS; Singh N
    Parasitol Res; 2020 Sep; 119(9):2991-3003. PubMed ID: 32748038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
    Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
    Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mianserin, an antidepressant kills Leishmania donovani by depleting ergosterol levels.
    Dinesh N; Kaur PK; Swamy KK; Singh S
    Exp Parasitol; 2014 Sep; 144():84-90. PubMed ID: 24950381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational studies on potential small molecule inhibitors of
    Boakye A; Gasu EN; Mensah JO; Borquaye LS
    J Biomol Struct Dyn; 2023; 41(21):12128-12141. PubMed ID: 36632757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a target-free high-throughput screening platform for the discovery of antileishmanial compounds.
    Corman HN; Shoue DA; Norris-Mullins B; Melancon BJ; Morales MA; McDowell MA
    Int J Antimicrob Agents; 2019 Oct; 54(4):496-501. PubMed ID: 31323307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Modeling and Virtual Screening Approach to Discover Potential Antileishmanial Inhibitors Against Ornithine Decarboxylase.
    Pandey RK; Prajapati P; Goyal S; Grover A; Prajapati VK
    Comb Chem High Throughput Screen; 2016; 19(10):813-823. PubMed ID: 27604958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
    Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
    J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cynaroside inhibits Leishmania donovani UDP-galactopyranose mutase and induces reactive oxygen species to exert antileishmanial response.
    Tabrez S; Rahman F; Ali R; Alouffi AS; Akand SK; Alshehri BM; Alshammari FA; Alam A; Alaidarous MA; Banawas S; Dukhyil AAB; Rub A
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33367614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro growth inhibitory activity of Medicines for Malaria Venture pathogen box compounds against Leishmania aethiopica.
    Tadele M; Abay SM; Asaga P; Makonnen E; Hailu A
    BMC Pharmacol Toxicol; 2021 Nov; 22(1):71. PubMed ID: 34784983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine-1,1-dioxide derivatives.
    Mangwegape DK; Zuma NH; Aucamp J; N'Da DD
    Arch Pharm (Weinheim); 2021 May; 354(5):e2000280. PubMed ID: 33491807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.